DFCO — Dalrada Financial Share Price
- $0.12m
- $6.38m
- $25.18m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.01 | ||
Price to Tang. Book | 0.15 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -150.99% | ||
Return on Equity | -364.07% | ||
Operating Margin | -82.51% |
Financial Summary
Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 1.18 | 3.41 | 19.27 | 29.74 | 25.18 | n/a | n/a | 222.52% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Dalrada Financial Corporation is a multi-national holding company that develops, manufactures, and sells a robust suite of products and services in the clean energy and health care sectors. The Company has five business divisions: Genefic, Dalrada Climate Technology, Dalrada Precision Manufacturing, Dalrada Technologies and Dalrada Corporate. Genefic delivers advanced health care solutions with products, services and systems. Genefic's pharmacy solution, Genefic Specialty Pharmacy, provides end-to-end prescription services as well as patient advocacy and support. Dalrada Climate Technology offers cutting-edge heat pump technology for industrial and residential applications. Dalrada Precision Manufacturing creates total manufacturing solutions. Dalrada Technologies creates digital products with computer information technology and software engineering services for a variety of technical industries and clients in both business-to-business (B2B) and business-to-customer (B2C) environments.
Directors
- Brian Bonar CHM (67)
- Fawad Nisar COO
- Stanley Costello EVP
- David Pickett EVP
- Robert Dietrich CAO (65)
- Eric Gaer VPR (63)
- Kelly Farley VPR
- Thomas Lizee VPR
- Gregory Remsen VPR
- Jose Arrieta DRC
- David Bacon DRC
- Ira Frohman DRC
- Tom Giles DRC
- Pauline Gourdie DRC
- Harvey Hershkowitz DRC
- Brian Kendrick DRC
- Bijan Kian DRC
- Kyle Mccollum DRC
- Vincent Monteparte DRC
- Amy Scannell DRC
- Anthony Zolezzi DRC (63)
- Last Annual
- June 30th, 2024
- Last Interim
- June 30th, 2024
- Incorporated
- May 12th, 1983
- Public Since
- November 10th, 1983
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Pink Sheets on Nasdaq
- Shares in Issue
- 120,157,113

- Address
- 600 LA TERRAZA BOULEVARD, ESCONDIDO, 92025
- Web
- https://dalrada.com/
- Phone
- +1 8582831253
- Auditors
- Macias Gini and O Connell, LLP
Upcoming Events for DFCO
Q1 2025 Dalrada Financial Corp Earnings Release
Q3 2025 Dalrada Financial Corp Earnings Release
Similar to DFCO
Aamaxan Transport
Pink Sheets on Nasdaq
ACCUSTEM SCIENCES
Pink Sheets on Nasdaq
Acutus Medical
Pink Sheets on Nasdaq
ADM Tronics Unlimited
Pink Sheets on Nasdaq
Advanced Biomedical Technologies
Pink Sheets on Nasdaq
FAQ
As of Today at 20:09 UTC, shares in Dalrada Financial are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in Dalrada Financial last closed at $0.00 and the price had moved by -99.49% over the past 365 days. In terms of relative price strength the Dalrada Financial share price has underperformed the S&P500 Index by -99.52% over the past year.
There is no consensus recommendation for this security.
Find out moreDalrada Financial does not currently pay a dividend.
Dalrada Financial does not currently pay a dividend.
Dalrada Financial does not currently pay a dividend.
To buy shares in Dalrada Financial you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in Dalrada Financial had a market capitalisation of $0.12m.
Here are the trading details for Dalrada Financial:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: DFCO
Based on an overall assessment of its quality, value and momentum Dalrada Financial is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Dalrada Financial. Over the past six months, its share price has underperformed the S&P500 Index by -98.71%.
As of the last closing price of $0.00, shares in Dalrada Financial were trading -99.09% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Dalrada Financial PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Dalrada Financial's management team is headed by:
- Brian Bonar - CHM
- Fawad Nisar - COO
- Stanley Costello - EVP
- David Pickett - EVP
- Robert Dietrich - CAO
- Eric Gaer - VPR
- Kelly Farley - VPR
- Thomas Lizee - VPR
- Gregory Remsen - VPR
- Jose Arrieta - DRC
- David Bacon - DRC
- Ira Frohman - DRC
- Tom Giles - DRC
- Pauline Gourdie - DRC
- Harvey Hershkowitz - DRC
- Brian Kendrick - DRC
- Bijan Kian - DRC
- Kyle Mccollum - DRC
- Vincent Monteparte - DRC
- Amy Scannell - DRC
- Anthony Zolezzi - DRC